NCT02302976View on ClinicalTrials.gov

GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2018

Conditions
Cocaine Dependence
Interventions
DRUG

cocaine hydrochloride

DRUG

exenatide

DRUG

placebo

Trial Locations (1)

06519

Connecticut Mental Health Center, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT02302976 - GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration | Biotech Hunter | Biotech Hunter